|1||NCT01770353||Active, not recruiting||MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment||
||45||All||18 Years and older (Adult, Senior)||NCT01770353||MM-398-01-01-02||November 2012||June 2018||June 2018||January 17, 2013||January 30, 2018||
|2||NCT02631733||Recruiting||Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors||
||48||All||18 Years and older (Adult, Senior)||NCT02631733||NCI-2015-02125
|July 15, 2016||July 1, 2019||December 16, 2015||January 23, 2018||
† Study has passed its completion date and status has not been verified in more than two years.